Free Trial

Insider Selling: Teladoc Health, Inc. (NYSE:TDOC) Insider Sells 4,174 Shares of Stock

Teladoc Health logo with Medical background

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) insider Fernando M. Rodrigues sold 4,174 shares of the stock in a transaction dated Tuesday, June 3rd. The stock was sold at an average price of $6.91, for a total transaction of $28,842.34. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Teladoc Health Price Performance

Shares of NYSE:TDOC traded down $0.20 on Thursday, reaching $6.93. 5,451,781 shares of the company traded hands, compared to its average volume of 6,260,843. The company's 50 day moving average is $7.18 and its 200-day moving average is $9.16. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. Teladoc Health, Inc. has a fifty-two week low of $6.35 and a fifty-two week high of $15.21. The stock has a market capitalization of $1.21 billion, a PE ratio of -1.20 and a beta of 1.82.

Institutional Trading of Teladoc Health

Several large investors have recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. increased its stake in shares of Teladoc Health by 18.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider's stock worth $22,213,000 after acquiring an additional 384,528 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Teladoc Health by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider's stock valued at $35,894,000 after acquiring an additional 22,664 shares during the period. Commonwealth Equity Services LLC lifted its stake in shares of Teladoc Health by 35.7% in the fourth quarter. Commonwealth Equity Services LLC now owns 113,563 shares of the health services provider's stock valued at $1,032,000 after buying an additional 29,903 shares during the period. Xponance Inc. lifted its stake in shares of Teladoc Health by 23.8% in the fourth quarter. Xponance Inc. now owns 13,861 shares of the health services provider's stock valued at $126,000 after buying an additional 2,661 shares during the period. Finally, Vanguard Group Inc. raised its position in Teladoc Health by 5.9% in the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider's stock worth $167,830,000 after purchasing an additional 1,029,829 shares in the last quarter. 76.82% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the company. Canaccord Genuity Group cut their target price on Teladoc Health from $14.00 to $12.00 and set a "buy" rating on the stock in a research report on Thursday, May 1st. Needham & Company LLC restated a "hold" rating on shares of Teladoc Health in a research note on Thursday, May 1st. Piper Sandler lowered their target price on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating for the company in a research note on Thursday, February 27th. Citigroup decreased their price target on Teladoc Health from $11.00 to $8.75 and set a "neutral" rating for the company in a research note on Friday, April 25th. Finally, Wells Fargo & Company decreased their target price on Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating for the company in a research note on Thursday, May 8th. Twelve equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $9.60.

View Our Latest Report on TDOC

About Teladoc Health

(Get Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Recommended Stories

Insider Buying and Selling by Quarter for Teladoc Health (NYSE:TDOC)

Should You Invest $1,000 in Teladoc Health Right Now?

Before you consider Teladoc Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.

While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines